- Home
- OFS vs SEER Comparison
OFS vs SEER Comparison
Compare OFS & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFS
- SEER
- Stock Information
- Founded
- OFS 2001
- SEER 2017
- Country
- OFS United States
- SEER United States
- Employees
- OFS N/A
- SEER N/A
- Industry
- OFS Finance/Investors Services
- SEER Medicinal Chemicals and Botanical Products
- Sector
- OFS Finance
- SEER Health Care
- Exchange
- OFS Nasdaq
- SEER Nasdaq
- Market Cap
- OFS 120.2M
- SEER 125.3M
- IPO Year
- OFS 2012
- SEER 2020
- Fundamental
- Price
- OFS $8.44
- SEER $2.16
- Analyst Decision
- OFS
- SEER Hold
- Analyst Count
- OFS 0
- SEER 1
- Target Price
- OFS N/A
- SEER $3.00
- AVG Volume (30 Days)
- OFS 60.0K
- SEER 207.2K
- Earning Date
- OFS 07-31-2025
- SEER 08-07-2025
- Dividend Yield
- OFS 16.19%
- SEER N/A
- EPS Growth
- OFS N/A
- SEER N/A
- EPS
- OFS 2.25
- SEER N/A
- Revenue
- OFS $44,026,000.00
- SEER $15,309,000.00
- Revenue This Year
- OFS N/A
- SEER $26.18
- Revenue Next Year
- OFS N/A
- SEER $29.58
- P/E Ratio
- OFS $3.73
- SEER N/A
- Revenue Growth
- OFS N/A
- SEER N/A
- 52 Week Low
- OFS $7.75
- SEER $1.56
- 52 Week High
- OFS $9.80
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- OFS 44.04
- SEER 51.02
- Support Level
- OFS $8.33
- SEER $1.94
- Resistance Level
- OFS $8.60
- SEER $2.03
- Average True Range (ATR)
- OFS 0.27
- SEER 0.08
- MACD
- OFS -0.05
- SEER -0.01
- Stochastic Oscillator
- OFS 13.86
- SEER 32.43
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.